The Audi Henderson Lake Las Vegas Classic is a non-profit event that benefits local charities throughout Henderson and Las Vegas.
It is our mission to raise funds for two or three beneficiaries we select each year. 100% of our net proceeds go to our chosen beneficiaries. As a registered non-profit event, part of your donation and purchase is tax deductible, please inquire for more information and details. In 2017 the event benefitted the following two charities.
100% of donations to Keep Memory Alive support Cleveland Clinic Lou Ruvo Center for Brain Health, which provides care to patients with memory and movement disorders.
At Keep Memory Alive, we’re committed to improving the lives of patients and their families as they navigate the extraordinary challenges of brain disorders. In Las Vegas, the Lou Ruvo Center for Brain Health treats patients with Alzheimer’s, Huntington’s and Parkinson’s disease, as well as frontotemporal dementia and multiple sclerosis.
The Lou Ruvo Center for Brain Health’s treatment programs are designed to provide excellent care and to respect the dignity of patients and their families. Research helps to advance Cleveland Clinic’s groundbreaking clinical trials and offers hope for improving brain health.
The Leukemia & Lymphoma Society of Southern Nevada. The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.
LLS exists to find cures and ensure access to treatments for blood cancer patients. We are the voice for all blood cancer patients and we work to ensure access to treatments for all blood cancer patients.
As there are no means of preventing or early screening for most blood cancers, the LLS research agenda is focused on finding cures. LLS drives research in areas of unmet medical need, and helps to bridge the gap between academic discovery and drug development. LLS identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies.